Clinical Trial

Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
Open-label, non-comparative, non-randomized clinical trial of the safety and tolerability of the drug MMH-450 in healthy volunteers consisting of 4 consecutive stages
Trial Details
NCT Number NCT07754279
Lead Sponsor Materia Medica Holding
Conditions Cough
Enrollment 16 participants
Start Date 2026-02-12
Primary Completion 2026-04-16 (estimated)
Study Completion 2026-05-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-10